In: Journal of Neurology, 2021, no. 268, p. 817–824
Background: Data on cancer prevalence and incidence in multiple sclerosis (MS) patients are controversial. This study is aimed at estimating cancer risk in MS patients. Methods: Nested case–control study using data collected between 01/01/1987 and 28/02/2016 from the United Kingdom Clinical Practice Research Datalink. Cancer diagnoses after first MS code (index date) was counted in 10,204 MS...
|
In: CardioVascular and Interventional Radiology, 2015, vol. 38, no. 3, p. 642-650
|
In: Virchows Archiv, 2015, vol. 466, no. 6, p. 637-643
|
In: Targeted Oncology, 2015, vol. 10, no. 2, p. 297-301
|
In: Angiogenesis, 2015, vol. 18, no. 3, p. 327-345
|
In: Cancer Immunology, Immunotherapy, 2015, vol. 64, no. 8, p. 1033-1046
|
In: Supportive Care in Cancer, 2015, vol. 23, no. 7, p. 1837-1839
|
In: Surgical Endoscopy, 2015, vol. 29, no. 11, p. 3363-3366
|
Mémoire de bachelor : Haute école de santé Genève, 2020.
Le cancer est une maladie fréquente, à laquelle les soignants sont de plus en plus confrontés (Office Fédérale de la Santé Publique [OFSP], 2019). Il ressort qu'il y a de l'insatisfaction pour les patients à propos de l'annonce de diagnostic (Brown et al., 2011). Le diagnostic d'une telle maladie est une épreuve pour le patient (Marx & Reich, 2009). C'est un moment de rupture biographique...
|
In: Cells, 2019, vol. 8, no. 8, p. 862
Liquid biopsy technologies have the potential to transform cancer patient management as it others non- invasive diagnosis and real-time monitoring of disease progression and treatment responses. The use of liquid biopsy for non-invasive cancer diagnosis can have pivotal importance for the African continent where access to medical infrastructures is limited, as it eliminates the need for...
|